Climb Bio · 2 days ago
Sr. Director, Clinical Pharmacology
Climb Bio is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. They are seeking an experienced Sr. Director, Clinical Scientist who will be responsible for the design, execution, and interpretation of clinical studies in support of Climb Bio’s development programs.
BiotechnologyHealth CareNeurosciencePharmaceutical
Responsibilities
Lead or co-lead the design and authoring of clinical protocols, amendments, and associated scientific documents
Define study objectives, endpoints, dose rationale, eligibility criteria, and biomarker strategies in collaboration with Medical Directors
Ensure studies are scientifically sound and aligned with the target product profile
Actively participate in study data review, including safety, PK/PD, and biomarker data
Partner with key business stakeholders to shape analyses and interpret outputs
Contribute to dose escalation and study design discussions and internal data review meetings
Work in close partnership with Medical Directors to support study execution and clinical decision making
Collaborate with Clinical Operations to balance scientific rigor with operational feasibility
Partner with key business stakeholders to ensure continuity across development stages
Contribute to regulatory documents and interactions, including briefing materials and responses
Support investigator engagement, KOL discussions, and advisory boards as a scientific representative
Contribute to development of best practices, templates, and standards for clinical science deliverables
Serve as a trusted scientific advisor to the CMO and development team
Qualification
Required
MD, PhD, PharmD, or equivalent advanced scientific degree
8+ years of experience in clinical development in biotech or pharma
Hands-on experience supporting and designing Phase 1 and Phase 2 clinical development
Strong protocol authoring and data interpretation experience
Experience contributing to regulatory submissions and interactions
Strong clinical and translational acumen
Facility with manipulating complex, multidimensional datasets
Excellent communication skills (written and oral)
Comfortable working in a collaborative, matrixed environment
Benefits
Discretionary annual bonus
Comprehensive benefits to include Medical, Dental and Vision
Life & Disability
401k company match
Generous paid time off
Equity
Company
Climb Bio
Immune-mediated diseases impact 1:7 people and are increasing in prevalence worldwide.
Funding
Current Stage
Public CompanyTotal Funding
$291.3MKey Investors
RA Capital Management
2024-04-11Post Ipo Equity· $120M
2021-08-10IPO
2021-05-24Series B· $60M
Recent News
2025-07-30
2025-07-30
Company data provided by crunchbase